Kim Seoung Hoon, Park Jang Ho, An Byoung Ho
National Cancer Center, Goyang-si 10408, Gyeonggi-do, Korea.
J Clin Med. 2022 Jul 24;11(15):4292. doi: 10.3390/jcm11154292.
Living donor liver transplantation (LDLT) is widely performed with good outcomes in the current era of improved surgical techniques. However, few studies have addressed how many human resources are required in the surgery itself. This study aimed to introduce how to perform LDLT with minimal manpower and evaluate the outcomes in adult patients.
The main surgical procedures of donor and recipient operations of LDLT were performed by a single specialist surgeon who led a team of minimal manpower that only included one fellow, one resident, one intern, and three nurses. He also provided postsurgical care and followed up all the patients as a primary care physician. The outcomes were analyzed from the standpoints of the feasibility and acceptability.
Between November 2018 and February 2020, a total of 47 patients underwent LDLT. Ten patients had ABO-incompatible donors. The median age of the overall recipients was 57 years old (36-71); 37 patients (78.7%) were male. The MELD score was 10 (6-40), and the main etiologies were hepatic malignancy (38 patients or 80.9%) and liver failure (9 patients or 19.1%). The median age of the overall donors was 34 years old (19-62); 22 patients (46.8%) were male. All the graft types were right liver except for one case of extended right liver with middle hepatic vein. All donors had an uneventful recovery with no complications. There was one intraoperative mortality due to cardiac arrest after reperfusion in one recipient. Hepatic artery thrombosis was developed in 5 (10.6%) recipients. An acute rejection episode occurred in one patient. The median follow-up period for all the patients was 32.9 months (range, 24.7-39.8). Biliary complications were developed in 11 (23.4%) recipients. In total, 7 (15%) patients died, including 1 intraoperative mortality, 5 from cancer recurrence, and 1 from intracranial hemorrhage. The 1-, 2-, and 3-year overall survival rates in the recipient group were 91.5%, 87.2%, and 85.1%, respectively.
LDLT with minimal surgical manpower is feasible under the supervision of a single expert surgeon who has the capacity for all the main surgical procedures in both donor and recipient operations without compromising the outcomes in the present era of advanced surgical management.
在当前手术技术不断改进的时代,活体肝移植(LDLT)广泛开展且效果良好。然而,很少有研究涉及手术本身需要多少人力资源。本研究旨在介绍如何以最少的人力进行LDLT,并评估成年患者的手术效果。
LDLT供体和受体手术的主要操作由一名专科医生完成,该医生带领一个人力最少的团队,团队成员仅包括一名住院医师、一名实习医师、一名实习生和三名护士。他还作为初级保健医生提供术后护理并随访所有患者。从可行性和可接受性的角度分析手术效果。
2018年11月至2020年2月,共有47例患者接受了LDLT。10例患者的供体与受体ABO血型不相容。所有受体的中位年龄为57岁(36 - 71岁);37例患者(78.7%)为男性。终末期肝病模型(MELD)评分中位数为10(6 - 40),主要病因是肝恶性肿瘤(38例患者,占80.9%)和肝衰竭(9例患者,占19.1%)。所有供体的中位年龄为34岁(19 - 62岁);22例患者(46.8%)为男性。除1例为带肝中静脉的扩大右肝外,所有移植物类型均为右肝。所有供体恢复顺利,无并发症发生。1例受体在再灌注后因心脏骤停发生术中死亡。5例(10.6%)受体发生肝动脉血栓形成。1例患者发生急性排斥反应。所有患者的中位随访时间为32.9个月(范围:24.7 - 39.8个月)。11例(23.4%)受体发生胆道并发症。共有7例(15%)患者死亡,包括1例术中死亡、5例因癌症复发死亡和1例因颅内出血死亡。受体组1年、2年和3年的总生存率分别为91.5%、87.2%和85.1%。
在一名能够独立完成供体和受体手术所有主要操作的专家外科医生的监督下,以最少的手术人力进行LDLT是可行的,且在当前先进手术管理时代不会影响手术效果。